Last updated on December 2018

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients


Brief description of study

To demonstrate the efficacy and safety of acarbose and metformin loose-dose combination as compared to metformin monotherapy in the treatment of subjects with T2DM that is inadequately controlled by metformin alone

Clinical Study Identifier: NCT03349684

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Chenzhou No. 1 People's Hospital
Chenzhou, China
  Connect »